Matches in Wikidata for { <http://www.wikidata.org/entity/Q66033733> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q66033733 description "clinical trial" @default.
- Q66033733 description "ensayu clínicu" @default.
- Q66033733 description "klinisch onderzoek" @default.
- Q66033733 description "клінічне випробування" @default.
- Q66033733 name "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 name "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 type Item @default.
- Q66033733 label "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 label "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 prefLabel "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 prefLabel "Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer" @default.
- Q66033733 P1132 Q66033733-ACE337B5-D396-44A3-AD0A-8675D20953D9 @default.
- Q66033733 P1476 Q66033733-C59FF476-628E-4997-A877-4387EA3304ED @default.
- Q66033733 P17 Q66033733-01731D6F-E757-4B0B-A4B4-84C989BC9033 @default.
- Q66033733 P17 Q66033733-0CB08DDB-5736-4B3D-977E-E255C731AB11 @default.
- Q66033733 P17 Q66033733-127A3753-ACB2-4241-8A15-AB162A7EF28A @default.
- Q66033733 P17 Q66033733-20D45187-DDFE-4087-A140-5C0B2D71669B @default.
- Q66033733 P17 Q66033733-2C9D16DC-A53C-424D-AEE9-5A6414820650 @default.
- Q66033733 P17 Q66033733-2EF1013F-B7BE-41FD-B03D-945E6DB74618 @default.
- Q66033733 P17 Q66033733-35ADF2AD-2B9B-4143-B2CF-1DB807376BC6 @default.
- Q66033733 P17 Q66033733-3D86A677-EC4A-4643-90F1-2E1CB44FD745 @default.
- Q66033733 P17 Q66033733-4AC47671-0F10-43FC-A007-37CDCFE07D28 @default.
- Q66033733 P17 Q66033733-5416A70A-1F4B-42DC-AD5D-6E8CB23FCDF3 @default.
- Q66033733 P17 Q66033733-6B6DACF2-1C11-4E91-ABEE-9192BB3C8914 @default.
- Q66033733 P17 Q66033733-727C682F-0526-4DEE-B6C5-6569E1D175C6 @default.
- Q66033733 P17 Q66033733-78F5A3A0-9A92-481E-A3C0-3069D94991C5 @default.
- Q66033733 P17 Q66033733-8D5E9D57-9FA1-4FF7-94A4-6C4E3132C29D @default.
- Q66033733 P17 Q66033733-8E435B61-C3BE-4A65-939E-5ECCCA7AAD6C @default.
- Q66033733 P17 Q66033733-8E84BC29-9E37-4E75-9FFC-371625D46B1D @default.
- Q66033733 P17 Q66033733-ACCF104F-02B0-4B3A-AE86-A4E802CC17E7 @default.
- Q66033733 P17 Q66033733-B28413B7-FC7C-4884-8C6A-AD57EFF258C3 @default.
- Q66033733 P17 Q66033733-BFB013D7-DBDE-4D1D-8639-FE301A1DD47D @default.
- Q66033733 P17 Q66033733-D015C9ED-8B1D-4D3F-BF6B-BF8E5984E677 @default.
- Q66033733 P17 Q66033733-D025FA22-2069-42B6-B24C-1EACF0A973AD @default.
- Q66033733 P17 Q66033733-D41E58D3-26F0-478F-8B9D-CD5DBFF90244 @default.
- Q66033733 P17 Q66033733-DAE02BA4-83A3-4BAD-9E60-0D056822C537 @default.
- Q66033733 P17 Q66033733-E033E842-1D54-4DD5-8CDA-DC6702B93C5A @default.
- Q66033733 P17 Q66033733-F2FA02D2-FF76-4B51-A1F4-29FD2F48EF8E @default.
- Q66033733 P2899 Q66033733-5C61B841-5845-44DF-8DF0-22655549E5DC @default.
- Q66033733 P3098 Q66033733-84F34271-6B57-4E94-86E3-061A50DFA0EE @default.
- Q66033733 P31 Q66033733-5D48F648-A3AC-45FC-8FEC-1142A77BC009 @default.
- Q66033733 P580 Q66033733-859FAAD7-4103-4D20-8AF4-CD10453AD9D3 @default.
- Q66033733 P582 Q66033733-36997D8D-E2EA-40C8-8A59-731B435AA33D @default.
- Q66033733 P6099 Q66033733-43CF5C01-B2C7-494E-88DB-59A7289971E0 @default.
- Q66033733 P8363 Q66033733-AEE340E0-A80F-4DB6-8F09-29C16572B6F2 @default.
- Q66033733 P1132 "+438" @default.
- Q66033733 P1476 "A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy" @default.
- Q66033733 P17 Q142 @default.
- Q66033733 P17 Q145 @default.
- Q66033733 P17 Q155 @default.
- Q66033733 P17 Q16 @default.
- Q66033733 P17 Q183 @default.
- Q66033733 P17 Q213 @default.
- Q66033733 P17 Q215 @default.
- Q66033733 P17 Q218 @default.
- Q66033733 P17 Q258 @default.
- Q66033733 P17 Q28 @default.
- Q66033733 P17 Q29 @default.
- Q66033733 P17 Q298 @default.
- Q66033733 P17 Q30 @default.
- Q66033733 P17 Q33 @default.
- Q66033733 P17 Q36 @default.
- Q66033733 P17 Q38 @default.
- Q66033733 P17 Q40 @default.
- Q66033733 P17 Q408 @default.
- Q66033733 P17 Q414 @default.
- Q66033733 P17 Q45 @default.
- Q66033733 P17 Q664 @default.
- Q66033733 P17 Q739 @default.
- Q66033733 P17 Q801 @default.
- Q66033733 P17 Q865 @default.
- Q66033733 P17 Q96 @default.
- Q66033733 P2899 "+18" @default.
- Q66033733 P3098 "NCT00081796" @default.
- Q66033733 P31 Q30612 @default.
- Q66033733 P580 "2004-04-01T00:00:00Z" @default.
- Q66033733 P582 "2006-09-01T00:00:00Z" @default.
- Q66033733 P6099 Q42824827 @default.
- Q66033733 P8363 Q78089383 @default.